Posts Tagged: Michael Garton
The injection of lab-made, healthy cells—referred to as a cell therapy — into a damaged heart could be a way to prevent that heart from failing. But to make this therapy a reality, the cells must be able to integrate and survive in patients’ bodies. That problem is exactly what Myoxa Therapeutics, the first-place winner at the Building a Biotech Pitch Competition, is working on solving.
A mixed filling dumpling with Myo Palate's cultivated pork and store-bought vegetable ingredients. The company has partnered with U of T Engineering professor Michael Garton (BME) on a project to further advance their technology.
The Leap into the Future series looks at emerging areas or aspects of regenerative medicine.
October 5, 2020 | Medicine by Design is supporting research aimed at advancing new concepts expected to be important to regenerative medicine in the coming years. The funded projects will have potential impacts in diseases and conditions such as vision loss, amyotrophic lateral sclerosis (ALS), intestinal disease in premature babies and more.
December 28, 2018 | After a climbing accident left him paralysed from the neck down, newly appointed University of Toronto Professor Michael Garton forged a new career in research
October 1, 2018 | Michael Garton joins IBBME to embark his research on designing "living drugs".
Showing 1 - 6 of 6 results